State Legislatures

The United States of America is just that --a group of united states. Under The U.S. Constitution, states have great latitude to craft state laws that, in many instances, are different than federal laws.

This is the case regarding the enforcement of marijuana laws and that is why it is very important that supporters of NORML's law reform efforts work hard at the state-level to effectively educate and lobby their state elected policy makers to substantially change America's arcane marijuana laws and replace them with legal controls similar to alcohol or decriminalize responsible adult use.

An important part of the legislative process is the committee or subcommittee hearing. When advocating for marijuana law reform, make sure that representatives of NORML are invited to participate and testify.

Since 1970, NORML has championed marijuana law reform in all 50 states. As a result, some states have legalized marijuana, many states have decriminalized marijuana possession and a majority of states and the District of Columbia have passed medical marijuana initiatives or laws. For more information please visit NORML's state laws section.

To stay on top of good or bad marijuana-related legislation in your state of interest and contact your elected policy makers, check out NORML's Legislative Alert section.

More importantly, citizens must be pro-active and recruit state representatives and senators to sponsor, co-sponsor or at the very least support the passage of common-sense marijuana law reform measures.

New Jersey: Testimony regarding marijuana’s classification as a “Schedule I” drug

Written testimony submitted to the NJ Division of Consumer Affairs regarding marijuana’s classification as a “Schedule I” drug in New Jersey. April 4, 2018

Maryland: Testimony in Support of SB 127

SB 127 amends minor marijuana possession penalties and further penalizes the use of cannabis inside a motor vehicle. April 3, 2018

Maryland: Testimony in Support of HB 1264

HB 1264 would put a question on the November ballot to let the voters decide on the issue of regulating the retail sale of marijuana for adult use. March 13, 2018

California: FDA Testimony

Evidence that cannabidiol (CBD) is a medically useful substance with negative abuse potential and should therefore not be scheduled as a controlled substance. Sept. 6, 2017

California: Testimony In Regard to: SB 65

Confirming that Cal NORML is withdrawing opposition to SB 65 in light of the amendments adopted by the Public Safety committee.

May 22, 2017

Kansas: Testimony In Regard to: HB 2152

Passage of HB 2152 Provides Necessary Access to Patients.
Paul Armentano, NORML Deputy Director, March 16, 2017.

NORML Driving Testimony

Submitted to: Maryland House of Delegates, Judicial Committee Annapolis, MD. In Regard to: HB 1236 / SB 891: Constitutional Amendment HB 1185 / SB 928: Marijuana Legalization. March 7, 2017

Maryland: Testimony Regarding the Regulation of Marijuana For Adult Use

Justin Strekal, NORML Political Director, March 2, 2017

California NORML: Opposition to AB 6

Dale Gieringer, Ph.D., Director, California NORML, February 20, 2017

California NORML: Oversight Hearings on MCRSA and Prop 64

Dale Gieringer, Ph.D., California NORML Executive Director, January 27, 2017